Comparative bioavailability of different formulations of MK-679 an orally active LTD4 receptor antagonist

L. Yogendran, K. McLaughlin, E. B. Vadas, D. J. Margolskee, S. Bechard, J. Y.K. Hseih, C. Lin, J. D. Rogers, D. G. Sciberras, I. M. James

Research output: Contribution to journalArticlepeer-review

2 Scopus citations
Original languageEnglish
Pages (from-to)169P-170P
JournalBritish Journal of Clinical Pharmacology
Volume34
Issue number2
StatePublished - 1992
Externally publishedYes

Cite this